BNTC News and Press, Benitec Biopharma Limited From 10/02/20

Mesoblast (MESO) -37% after FDA rejects cell therapy application for treatment-resistant graft-vs-host disease.Benitec Biopharma (BNTC) -26%.Greenpro Capital (GRNQ) -18%.Tuniu (TOUR) -14%.Hall of Fame Resort & Entertainment (HOFV) -13%.Iterum Therapeutics (ITRM) -12%.Oxbridge Re...

Gainers: Solid Biosciences (SLDB) +114%.Enlivex Therapeutics (ENLV) +45%.AMAG Pharmaceuticals (AMAG) +45%.American Equity Investment Life (AEL) +40%.Gridsum (GSUM) +36%.Bed Bath & Beyond (BBBY) +33%.Watford Holdings (WTRE) +26%.Advanced Emissions Solutions (ADES) +25%.Westwater Resou...

Benitec (BNTC): FY GAAP EPS of -$8.10.Revenue of $0.1M (-99.2% Y/Y)Press Release For further details see: Benitec reports FY results

Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results PR Newswire HAYWARD, Calif., Sept. 23, 2020 HAYWARD, Calif. , Sept. 23, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Co...

HAYWARD, Calif. , Sept. 1, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that ...

HAYWARD, Calif. , July 8, 2020 /PRNewswire/ --   Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced the...

Gainers: Cyclacel Pharmaceuticals (NASDAQ: CYCC )  +91% . More news on: Cyclacel Pharmaceuticals, Inc., Benitec Biopharma Limited, VBI Vaccines Inc., Stocks on the move, , Read more ...

Benitec Biopharma Limited (NASDAQ: BNTC ) initiated with Buy rating and $14 (140% upside) price target at Ladenburg Thalmann. More news on: Benitec Biopharma Limited, AbbVie Inc., Gilead Sciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

HAYWARD, Calif. , April 14, 2020 /PRNewswire/ --  Benitec Biopharma, Inc., a successor entity to Benitec Biopharma Limited (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today announced the appointment of Edward Smit...

MELBOURNE, Australia , March 30, 2020 /PRNewswire/ -- Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group fr...